47th week of 2020 patent applcation highlights part 9 |
Patent application number | Title | Published |
20200360341 | INDOMETHACIN MENTHYL ESTER-BASED PHARMACEUTICAL COMPOSITIONS AND THEIR USE AS ANTI-INFLAMMATORY AGENTS | 2020-11-19 |
20200360342 | ARYL-SUBSTITUTED ACETAMIDE AND PYRROLIDIN-2-ONE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SEIZURES | 2020-11-19 |
20200360343 | 1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS | 2020-11-19 |
20200360344 | ANTIMICROBIAL DRUG SYNTHESIS AND THERAPEUTIC COMPOSITIONS | 2020-11-19 |
20200360345 | COMPOSITIONS AND METHODS FOR NON-SURGICAL TREATMENT OF PTOSIS | 2020-11-19 |
20200360346 | COMPOSITIONS AND METHODS FOR TREATING PRESBYOPIA | 2020-11-19 |
20200360347 | CENICRIVIROC FOR THE TREATMENT OF FIBROSIS | 2020-11-19 |
20200360348 | COMPOUNDS, COMPOSITIONS, AND METHODS OF INCREASING CFTR ACTIVITY | 2020-11-19 |
20200360350 | TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE OR PREVENT ANAPHYLAXIS IN RESPONSE TO A NON-ALLERGENIC ANTIGEN | 2020-11-19 |
20200360351 | METHODS AND COMPOUNDS FOR THE TREATMENT OR PREVENTION OF HYPERCYTOKINEMIA AND SEVERE INFLUENZA | 2020-11-19 |
20200360352 | USE OF RIFAMYCIN-NITROIMIDAZOLE COUPLING MOLECULE | 2020-11-19 |
20200360353 | MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS | 2020-11-19 |
20200360354 | METHODS FOR THE ADMINISTRATION OF CERTAIN VMAT2 INHIBITORS | 2020-11-19 |
20200360355 | ENHANCERS OF NOTCH SIGNALING AND THEIR USE THEREOF IN THE TREATMENT OF CANCERS AND MALIGNANCIES MEDICABLE BY UPREGULATION OF NOTCH | 2020-11-19 |
20200360356 | SULFASALAZINE SALTS, PRODUCTION PROCESSES AND USES | 2020-11-19 |
20200360357 | Pyridinone derivatives and their use as selective ALK-2 inhibitors | 2020-11-19 |
20200360358 | METHOD OF TREATMENT WITH TRADIPITANT | 2020-11-19 |
20200360359 | TREATMENT OF CANCER BY STIMULATION OF IL-12 PRODUCTION | 2020-11-19 |
20200360360 | PHARMACEUTICAL COMPOSITIONS OF TEDIZOLID PHOSPHATE | 2020-11-19 |
20200360361 | Anti-Androgens For The Treatment Of Non-Metastatic Castration-Resistant Prostate Cancer | 2020-11-19 |
20200360362 | SUSTAINED-RELEASE TRIPTAN COMPOSITIONS AND METHOD OF USE THE SAME THROUGH SUBDERMAL ROUTE OR THE LIKE | 2020-11-19 |
20200360363 | THERAPEUTIC AGENT FOR MENTAL RETARDATION OR AUTISM | 2020-11-19 |
20200360364 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY OR AUTOIMMUNE DISEASES OR CONDITIONS USING CHRNA6 ACTIVATORS | 2020-11-19 |
20200360365 | SUBSTITUTED HALO-QUINOLINE DERIVATES FOR USE IN THE TREATMENT OF LYMPHOMAS AND LEUKEMIA | 2020-11-19 |
20200360366 | PROLYLHYDROXYLASE/ATF4 INHIBITORS AND METHODS OF USE FOR TREATING NEURAL CELL INJURY OR DEATH AND CONDITIONS RESULTING THEREFROM | 2020-11-19 |
20200360367 | Treatment of Breast Cancer with Liposomal Irinotecan | 2020-11-19 |
20200360368 | MULTIDIRECTIONAL MUCOSAL DELIVERY DEVICES AND METHODS OF USE | 2020-11-19 |
20200360369 | SMART BROADCAST DEVICE | 2020-11-19 |
20200360370 | METHOD OF PROVIDING ARIPIPRAZOLE TO PATIENTS HAVING IMPAIRED CYP2D6 OR CYP3A4 ENZYME FUNCTION | 2020-11-19 |
20200360371 | Combination Therapies for the Treatment of Hepatocellular Carcinoma | 2020-11-19 |
20200360372 | COMBINATION THERAPY FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA | 2020-11-19 |
20200360373 | CONTROLLED-RELEASE PREPARATION | 2020-11-19 |
20200360374 | DOSING OF KRAS INHIBITOR FOR TREATMENT OF CANCERS | 2020-11-19 |
20200360375 | SMALL MOLECULE WNT INHIBITOR AS TREATMENT FOR DYSLIPIDEMIA | 2020-11-19 |
20200360376 | INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF | 2020-11-19 |
20200360377 | INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF | 2020-11-19 |
20200360378 | PHARMACEUTICAL COMPOSITIONS COMPRISING AZD9291 | 2020-11-19 |
20200360379 | HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS | 2020-11-19 |
20200360380 | CANCERS EXPRESSING CCR5 AND METHODS OF TREATMENT OF SAME | 2020-11-19 |
20200360381 | COMPOUNDS FOR TREATING DENGUE VIRUS INFECTION AND OTHER VIRAL INFECTIONS | 2020-11-19 |
20200360382 | 3-(SUBSTITUTED-4-OXOQUINAZOLIN-3(4H)-YL)-3-DEUTERO-PIPERIDINE-2,6-DIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | 2020-11-19 |
20200360383 | Quinazoline Compounds | 2020-11-19 |
20200360384 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | 2020-11-19 |
20200360385 | INDUCTION OF IMMUNE TOLERANCE BY USING METHOTREXATE | 2020-11-19 |
20200360386 | Inhibitors of HSP90, PI3-Kinase, Proteasome, HDAC, and P97 Pathways for Selective Removal of Senescent Cells in the Treatment of Age Related Conditions | 2020-11-19 |
20200360387 | CYCLOALKYL SUBSTITUTED PYRAZOLOPYRIMIDINES HAVING ACTIVITY AGAINST RSV | 2020-11-19 |
20200360388 | ALPHA POLYGLUTAMATED PEMETREXED AND USES THEREOF | 2020-11-19 |
20200360389 | GAMMA POLYGLUTAMATED ANTIFOLATES AND USES THEREOF | 2020-11-19 |
20200360390 | ALPHA POLYGLUTAMATED PRALATREXATE AND USES THEREOF | 2020-11-19 |
20200360391 | Medicinal Composition for Treating Intractable Heart Disease | 2020-11-19 |
20200360392 | DIGALLIC ACID FOR REDUCTION OF INFLAMMATORY CYTOKINE ACTIVITY | 2020-11-19 |
20200360393 | USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)-KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN | 2020-11-19 |
20200360394 | THERAPIES WITH 3RD GENERATION EGFR TYROSINE KINASE INHIBITORS | 2020-11-19 |
20200360395 | SALTS AND SOLID FORMS OF (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDIN- E-2,6-DIONE AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | 2020-11-19 |
20200360396 | 3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS | 2020-11-19 |
20200360397 | ANTI-VIRAL COMPOSITIONS CONTAINING PIKFYVE INHIBITORS AND USE THEREOF | 2020-11-19 |
20200360398 | METHODS FOR TREATING HYPERSOMNIA | 2020-11-19 |
20200360399 | COMPOUNDS THAT INHIBIT MCL-1 PROTEIN | 2020-11-19 |
20200360400 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ADDICTION, PSYCHIATRIC DISORDERS, AND NEURODEGENERATIVE DISEASE | 2020-11-19 |
20200360401 | USE OF CORTISOL IN ASSESSMENT AND PROPHYLACTIC TREATMENT OF HYPOKALEMIA ASSOCIATED WITH GLUCOCORTICOID RECEPTOR MODULATOR TREATMENT OF CUSHING'S SYNDROME PATIENTS | 2020-11-19 |
20200360402 | HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS | 2020-11-19 |
20200360403 | OPTHALMIC COMPOSITIONS FOR INHIBITING CLOUDING OF THE OCULAR LENS | 2020-11-19 |
20200360404 | TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY | 2020-11-19 |
20200360405 | COMPOSITIONS AND METHODS FOR REDUCING LOCAL AND SYSTEMIC RISKS OF ENVENOMATION | 2020-11-19 |
20200360406 | SELECTIVE ACCRETION OF CYTOPROTECTANT IN RADIATION-SENSITIVE TISSUES AND USES THEREOF | 2020-11-19 |
20200360407 | COMPOSITIONS COMPRISING AT LEAST ONE N-ACETYLATED AND AT LEAST ONE FUCOSYLATED OLIGOSACCHARIDE FOR USE IN THE PROMOTION OF DIGESTIVE CAPACITY IN INFANTS AND YOUNG CHILDREN | 2020-11-19 |
20200360408 | Compositions And Methods For Inducing Apoptosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections | 2020-11-19 |
20200360409 | BIOCONVERSION OF OLEUROPEIN | 2020-11-19 |
20200360410 | COMPOSITION FOR PREVENTING OR TREATING NEUROLOGICAL DISORDER COMPRISING AUCUBIN | 2020-11-19 |
20200360411 | REPURPOSCINS: TARGETED INHIBITORS OF MITOCHONDRIAL BIOGENESIS FOR ERADICATING CANCER STEM CELLS | 2020-11-19 |
20200360412 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | 2020-11-19 |
20200360413 | Composition and Methods of Treating Acne and Photoaging | 2020-11-19 |
20200360414 | MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING | 2020-11-19 |
20200360415 | BISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF | 2020-11-19 |
20200360416 | NOVEL 6-6 BICYCLIC AROMATIC RING SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS | 2020-11-19 |
20200360417 | ROR2 INHIBITORS AND USE THEREOF IN TREATING AND/OR PREVENTING CARTILAGE LOSS | 2020-11-19 |
20200360418 | AUTOBIOTIC COMPOSITIONS AND METHOD FOR PROMOTING HEALTHY GUT MICROBIOME | 2020-11-19 |
20200360419 | CHITOSAN MATERIALS FROM CARBONIC ACID SOLUTION | 2020-11-19 |
20200360420 | COMPOSITIONS COMPRISING AN RNA POLYMERASE INHIBITOR AND CYCLODEXTRIN FOR TREATING VIRAL INFECTIONS | 2020-11-19 |
20200360421 | COMPOSITION IN SOLID FORM FOR USE IN THE TREATMENT OF EXTRAOESOPHAGEAL SYMPTOMS OF GASTRIC REFLUX | 2020-11-19 |
20200360422 | COMPOSITIONS COMPRISING SULFATED POLYSACCHARIDES | 2020-11-19 |
20200360423 | SOLID CONCENTRATED CONSTIPATION TREATMENT FORMULATIONS | 2020-11-19 |
20200360424 | COMPOSITIONS OF NITRATES AND METHODS OF USE THEREOF | 2020-11-19 |
20200360425 | Use Of Inhaled Nitric Oxide And Oxygen For The Treatment Of Pulmonary Hypertension | 2020-11-19 |
20200360426 | PROTOCOL AND COMPOSITION FOR SUPPRESSION OF ALLERGIC RESPONSES | 2020-11-19 |
20200360427 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING DISEASES ASSOCIATED WITH OXIDATIVE STRESS | 2020-11-19 |
20200360428 | Methods of Reducing Doses of Erythropoietin Stimulating Agents in Hyporesponsive Patients | 2020-11-19 |
20200360429 | ANTI-INFLAMMATORY COMPOSITION COMPRISING GRAPHENE NANO-STRUCTURE | 2020-11-19 |
20200360430 | EXTRACELLULAR MATRIX COMPOSITIONS FOR THE TREATMENT OF CANCER | 2020-11-19 |
20200360431 | BCMA-TARGETING CHIMERIC ANTIGEN RECEPTOR, CD19-TARGETING CHIMERIC ANTIGEN RECEPTOR, AND COMBINATION THERAPIES | 2020-11-19 |
20200360432 | POLYPEPTIDE | 2020-11-19 |
20200360433 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2020-11-19 |
20200360434 | NKP30 RECEPTOR TARGETED THERAPEUTICS | 2020-11-19 |
20200360435 | T-CELL RECEPTOR | 2020-11-19 |
20200360436 | NK CELLS WITH AN INCREASED ANTIBODY-DEPENDENT CELLULAR TOXICITY (ADCC) AGAINST TUMORS | 2020-11-19 |
20200360437 | CHIMERIC ANTIGEN RECEPTOR, NKG2D CAR-NK CELLS EXPRESSING THE CHIMERIC ANTIGEN RECEPTOR, AND PREPARATION AND APPLICATION THEREOF | 2020-11-19 |
20200360438 | ENHANCING THE EFFECT OF CAR-ENGINEERED T CELLS BY MEANS OF NUCLEIC ACID VACCINATION | 2020-11-19 |
20200360439 | ENGINEERED CHIMERIC GUIDE RNA AND USES THEREOF | 2020-11-19 |
20200360440 | STEM CELL MATERIAL, COMPOSITIONS, AND METHODS OF USE | 2020-11-19 |
20200360441 | POST-NATAL TRANSPLANTATION OF FACTOR VIII-EXPRESSING CELLS FOR TREATMENT OF HEMOPHILIA | 2020-11-19 |